Trilac is a probiotic medication containing beneficial bacteria that help maintain healthy gut flora. It is being studied for its potential effects in reducing the symptoms and disease activity in multiple sclerosis patients.

Lacidofil is also a probiotic medication containing specific strains of beneficial bacteria. Like Trilac, it is being investigated for its potential role in managing multiple sclerosis symptoms through its effects on gut health and immune system function.

Both medications represent a new approach to treating multiple sclerosis by focusing on the relationship between gut bacteria and immune system function. These probiotics are generally considered safe and are already used for various digestive health conditions.

Multiple Sclerosis – A chronic disease affecting the central nervous system where the immune system damages the protective covering of nerve fibers. The disease typically causes inflammation and damage to myelin in the brain and spinal cord, disrupting communication between different parts of the nervous system. Symptoms can include fatigue, difficulty walking, vision problems, muscle weakness, and problems with coordination and balance. The disease usually follows a pattern of relapses and remissions, where symptoms may flare up and then improve. Multiple sclerosis affects each person differently, with varying patterns of symptoms and progression over time.